Cognition Therapeutics Inc (CGTX) stock
CGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.60−0.03 (-4.75%)
Close on Nov 18, 2026Market cap $57.06MP/E –Yield –
Cognition Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cognition Therapeutics's operating income for the twelve months ending Jun 30, 2026 was -$36.60M. For fiscal 2025 it was -$47.80M. The highest annual figure on record is -$17.41M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$47.80M | – |
| FY2024 | Dec 31, 2024 | -$53.97M | – |
| FY2023 | Dec 31, 2023 | -$50.72M | – |
| FY2022 | Dec 31, 2022 | -$43.55M | – |
| FY2021 | Dec 31, 2021 | -$28.60M | – |
| FY2020 | Dec 31, 2020 | -$17.41M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.74M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.82M | – |
| Q4 FY2025 | Dec 31, 2025 | -$13.67M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.38M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.98M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.78M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.72M | – |
| Q3 FY2024 | Sep 30, 2024 | -$14.46M | – |
| Q2 FY2024 | Jun 30, 2024 | -$14.68M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.10M | – |
| Q4 FY2023 | Dec 31, 2023 | -$15.19M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.75M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.82M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.97M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.30M | – |
| Q3 FY2022 | Sep 30, 2022 | -$12.63M | – |
| Q2 FY2022 | Jun 30, 2022 | -$12.21M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.41M | – |
| Q4 FY2021 | Dec 31, 2021 | -$11.81M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.22M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.98M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.58M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.12M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.46M | – |
See a number that looks wrong?